PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
86.64%
Revenue growth above 1.5x AR's 23.58%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
224.24%
Gross profit growth above 1.5x AR's 54.81%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
23983.33%
EBIT growth above 1.5x AR's 283.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
23983.33%
Operating income growth above 1.5x AR's 283.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2022.22%
Net income growth above 1.5x AR's 264.09%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1992.86%
EPS growth above 1.5x AR's 264.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1992.86%
Diluted EPS growth above 1.5x AR's 251.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.92%
Share count expansion well above AR's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
-3.59%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-8.87%
Negative OCF growth while AR is at 51.96%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-28.64%
Negative FCF growth while AR is at 50.46%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-23.01%
Negative 10Y revenue/share CAGR while AR stands at 1363.17%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
168.71%
5Y revenue/share CAGR at 75-90% of AR's 222.20%. Bill Ackman would encourage strategies to match competitor’s pace.
3.04%
3Y revenue/share CAGR under 50% of AR's 57.48%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-62.17%
Negative 10Y OCF/share CAGR while AR stands at 268.45%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
145.99%
5Y OCF/share CAGR above 1.5x AR's 42.07%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-2.73%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
419.26%
Below 50% of AR's 10716.26%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
425.81%
5Y net income/share CAGR 1.25-1.5x AR's 286.17%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-1.27%
Negative 3Y CAGR while AR is 834.85%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-82.36%
Negative equity/share CAGR over 10 years while AR stands at 185.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-45.21%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-49.93%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-86.10%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
70.10%
Dividend/share CAGR of 70.10% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
103.48%
3Y dividend/share CAGR of 103.48% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.74%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
3.07%
Similar asset growth to AR's 3.15%. Walter Schloss finds parallel expansions or investment rates.
32.42%
BV/share growth above 1.5x AR's 18.08%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.22%
We’re deleveraging while AR stands at 4.42%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.79%
We expand SG&A while AR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.